{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:54:51Z","timestamp":1781776491494,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Heilongjiang University of Chinese Medicine Young Researchers Scientific and Technological Innovation Capacity Cultivation Project","award":["2024XJJ-QNCX023\uff1b2024-KYYWF-1392"],"award-info":[{"award-number":["2024XJJ-QNCX023\uff1b2024-KYYWF-1392"]}]},{"name":"Heilongjiang University of Traditional Chinese Medicine \"Double First Class\" Discipline Development Assistance Fund","award":["GJJGSPZDXK31003"],"award-info":[{"award-number":["GJJGSPZDXK31003"]}]},{"name":"NSFC Cultivation Support Program, First Affiliated Hospital, Heilongjiang University of Chinese Medicine","award":["PYQN202501008"],"award-info":[{"award-number":["PYQN202501008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05564-4","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:12:23Z","timestamp":1778663543000},"page":"2691-2712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TangShenKang decoction plays an anti-inflammatory and anti-fibrotic role in diabetic nephropathy by activating AT2R\/ATIP1\/SHP1 axis and antagonizing angiotensin II"],"prefix":"10.1007","volume":"481","author":[{"given":"Ran","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"5564_CR1","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.2337\/dci23-0030","volume":"46","author":"SC Naaman","year":"2023","unstructured":"Naaman SC, Bakris GL (2023) Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression. Diabetes Care 46:1574\u20131586. https:\/\/doi.org\/10.2337\/dci23-0030","journal-title":"Diabetes Care"},{"key":"5564_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4093\/dmj.2020.0217","volume":"45","author":"T Yamazaki","year":"2021","unstructured":"Yamazaki T, Mimura I, Tanaka T, Nangaku M (2021) Treatment of Diabetic Kidney Disease: Current and Future. Diabetes metabolism J 45:11\u201326. https:\/\/doi.org\/10.4093\/dmj.2020.0217","journal-title":"Diabetes metabolism J"},{"key":"5564_CR3","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/ndt\/gfad101","volume":"38","author":"R Whitlock","year":"2023","unstructured":"Whitlock R et al (2023) The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis. Nephrol dialysis transplantation: official publication Eur Dialysis Transpl Association - Eur Ren Association 38:2503\u20132516. https:\/\/doi.org\/10.1093\/ndt\/gfad101","journal-title":"Nephrol dialysis transplantation: official publication Eur Dialysis Transpl Association - Eur Ren Association"},{"key":"5564_CR4","doi-asserted-by":"publisher","unstructured":"Mazzieri A, Porcellati F, Timio F, Reboldi G (2024) Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25073969","DOI":"10.3390\/ijms25073969"},{"key":"5564_CR5","doi-asserted-by":"publisher","unstructured":"Tain YL, Hsu CN (2024) The Renin-Angiotensin System and Cardiovascular-Kidney-Metabolic Syndrome: Focus on Early-Life Programming. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25063298","DOI":"10.3390\/ijms25063298"},{"key":"5564_CR6","doi-asserted-by":"publisher","unstructured":"Fatima N, Patel SN, Hussain T (2021) Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling. Hypertension. 77, 1845\u20131856. https:\/\/doi.org\/10.1161\/hypertensionaha.120.11941","DOI":"10.1161\/hypertensionaha.120.11941"},{"key":"5564_CR7","doi-asserted-by":"publisher","first-page":"111259","DOI":"10.1016\/j.mce.2021.111259","volume":"529","author":"F Rianto","year":"2021","unstructured":"Rianto F, Hoang T, Revoori R, Sparks MA (2021) Angiotensin receptors in the kidney and vasculature in hypertension and kidney disease. Mol Cell Endocrinol 529:111259. https:\/\/doi.org\/10.1016\/j.mce.2021.111259","journal-title":"Mol Cell Endocrinol"},{"key":"5564_CR8","doi-asserted-by":"publisher","unstructured":"Bhullar SK, Dhalla NS (2022) Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy. Cells. https:\/\/doi.org\/10.3390\/cells11213336","DOI":"10.3390\/cells11213336"},{"key":"5564_CR9","doi-asserted-by":"publisher","first-page":"28989","DOI":"10.1074\/jbc.M403880200","volume":"279","author":"S Nouet","year":"2004","unstructured":"Nouet S et al (2004) Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 279:28989\u201328997. https:\/\/doi.org\/10.1074\/jbc.M403880200","journal-title":"J Biol Chem"},{"key":"5564_CR10","doi-asserted-by":"publisher","first-page":"100850","DOI":"10.1016\/j.bbrep.2020.100850","volume":"24","author":"K Soda","year":"2020","unstructured":"Soda K, Nakada Y, Iwanari H, Hamakubo T (2020) AT2 receptor interacting protein 1 (ATIP1) mediates COX-2 induction by an AT2 receptor agonist in endothelial cells. Biochem Biophys Rep 24:100850. https:\/\/doi.org\/10.1016\/j.bbrep.2020.100850","journal-title":"Biochem Biophys Rep"},{"key":"5564_CR11","doi-asserted-by":"publisher","unstructured":"Lim S, Lee KW, Kim JY, Kim KD (2023) Consideration of SHP-1 as a Molecular Target for Tumor Therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25010331","DOI":"10.3390\/ijms25010331"},{"key":"5564_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.kint.2023.06.038","volume":"104","author":"F Lizotte","year":"2023","unstructured":"Lizotte F et al (2023) Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease. Kidney Int 104:787\u2013802. https:\/\/doi.org\/10.1016\/j.kint.2023.06.038","journal-title":"Kidney Int"},{"key":"5564_CR13","doi-asserted-by":"publisher","first-page":"118179","DOI":"10.1016\/j.jep.2024.118179","volume":"330","author":"XX Gong","year":"2024","unstructured":"Gong XX, Cao LH, Ni HX, Zang ZY, Chang H (2024) Chinese herbal medicine for the treatment of diabetic nephropathy: From clinical evidence to potential mechanisms. J Ethnopharmacol 330:118179. https:\/\/doi.org\/10.1016\/j.jep.2024.118179","journal-title":"J Ethnopharmacol"},{"key":"5564_CR14","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2147\/dddt.S411211","volume":"17","author":"M Guo","year":"2023","unstructured":"Guo M, Gao J, Jiang L, Dai Y (2023) Astragalus polysaccharide ameliorates renal inflammatory responses in a diabetic nephropathy by suppressing the TLR4\/NF-\u03baB pathway. Drug Des Devel Ther 17:2107\u20132118. https:\/\/doi.org\/10.2147\/dddt.S411211","journal-title":"Drug Des Devel Ther"},{"key":"5564_CR15","doi-asserted-by":"publisher","first-page":"10823","DOI":"10.1080\/21655979.2021.1967035","volume":"12","author":"L Lu","year":"2021","unstructured":"Lu L et al (2021) Angiotensin (ang) 1\u20137 inhibits ang II-induced atrial fibrosis through regulating the interaction of proto-oncogene tyrosine-protein kinase Src (c-Src) and Src homology region 2 domain-containing phosphatase-1 (SHP-1)). Bioengineered 12:10823\u201310836. https:\/\/doi.org\/10.1080\/21655979.2021.1967035","journal-title":"Bioengineered"},{"key":"5564_CR16","doi-asserted-by":"publisher","first-page":"154915","DOI":"10.1016\/j.phymed.2023.154915","volume":"118","author":"Y Liu","year":"2023","unstructured":"Liu Y et al (2023) Network pharmacology-based study on the mechanism of ShenKang injection in diabetic kidney disease through Keap1\/Nrf2\/Ho-1 signaling pathway. Phytomedicine: Int J phytotherapy phytopharmacology 118:154915. https:\/\/doi.org\/10.1016\/j.phymed.2023.154915","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"5564_CR17","doi-asserted-by":"publisher","unstructured":"Tang H, Li K, Shi Z, Wu J (2025) G-Protein-coupled receptors in chronic kidney disease induced by hypertension and diabetes. Cells. https:\/\/doi.org\/10.3390\/cells14100729","DOI":"10.3390\/cells14100729"},{"key":"5564_CR18","doi-asserted-by":"publisher","first-page":"110712","DOI":"10.1016\/j.cellsig.2023.110712","volume":"108","author":"D Qiu","year":"2023","unstructured":"Qiu D et al (2023) NQO1 alleviates renal fibrosis by inhibiting the TLR4\/NF-\u03baB and TGF-\u03b2\/Smad signaling pathways in diabetic nephropathy. Cell Signal 108:110712. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110712","journal-title":"Cell Signal"},{"key":"5564_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4093\/dmj.2021.0329","volume":"46","author":"CY Jung","year":"2022","unstructured":"Jung CY, Yoo TH (2022) Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease. Diabetes metabolism J 46:181\u2013197. https:\/\/doi.org\/10.4093\/dmj.2021.0329","journal-title":"Diabetes metabolism J"},{"key":"5564_CR20","doi-asserted-by":"publisher","first-page":"154381","DOI":"10.1016\/j.phymed.2022.154381","volume":"105","author":"M Gu","year":"2022","unstructured":"Gu M et al (2022) Chrysophanol, a main anthraquinone from Rheum palmatum L. (rhubarb), protects against renal fibrosis by suppressing NKD2\/NF-\u03baB pathway. Phytomedicine: Int J phytotherapy phytopharmacology 105:154381. https:\/\/doi.org\/10.1016\/j.phymed.2022.154381","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"5564_CR21","doi-asserted-by":"publisher","first-page":"155129","DOI":"10.1016\/j.phymed.2023.155129","volume":"121","author":"Z Shen","year":"2023","unstructured":"Shen Z et al (2023) Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the gut-kidney axis. Phytomedicine: Int J phytotherapy phytopharmacology 121:155129. https:\/\/doi.org\/10.1016\/j.phymed.2023.155129","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"5564_CR22","doi-asserted-by":"publisher","first-page":"154975","DOI":"10.1016\/j.phymed.2023.154975","volume":"119","author":"Z Zhu","year":"2023","unstructured":"Zhu Z et al (2023) Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1\/PINK1 signaling in tubular cells. Phytomedicine: Int J phytotherapy phytopharmacology 119:154975. https:\/\/doi.org\/10.1016\/j.phymed.2023.154975","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"key":"5564_CR23","doi-asserted-by":"publisher","first-page":"115899","DOI":"10.1016\/j.biopha.2023.115899","volume":"169","author":"H Yu","year":"2023","unstructured":"Yu H et al (2023) Effects of total flavones of Abelmoschus manihot (L.) on the treatment of diabetic nephropathy via the activation of solute carriers in renal tubular epithelial cells. Biomed pharmacotherapy = Biomedecine pharmacotherapie 169:115899. https:\/\/doi.org\/10.1016\/j.biopha.2023.115899","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"5564_CR24","doi-asserted-by":"publisher","first-page":"119476","DOI":"10.1016\/j.jep.2025.119476","volume":"343","author":"YA Wang","year":"2025","unstructured":"Wang YA et al (2025) Evaluation of anti-hyperuricemic and nephroprotective activities and discovery of new XOD inhibitors of Morus alba L. root bark. J Ethnopharmacol 343:119476. https:\/\/doi.org\/10.1016\/j.jep.2025.119476","journal-title":"J Ethnopharmacol"},{"key":"5564_CR25","doi-asserted-by":"publisher","unstructured":"Wang Y et al (2022) The Novel AT2 Receptor Agonist \u03b2-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232214039","DOI":"10.3390\/ijms232214039"},{"key":"5564_CR26","doi-asserted-by":"publisher","first-page":"114598","DOI":"10.1016\/j.biopha.2023.114598","volume":"163","author":"Y Gao","year":"2023","unstructured":"Gao Y, Su X, Xue T, Zhang N (2023) The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease. Biomed pharmacotherapy = Biomedecine pharmacotherapie 163:114598. https:\/\/doi.org\/10.1016\/j.biopha.2023.114598","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"5564_CR27","doi-asserted-by":"publisher","first-page":"1429420","DOI":"10.3389\/fendo.2024.1429420","volume":"15","author":"DM Zhao","year":"2024","unstructured":"Zhao DM, Zhong R, Wang XT, Yan ZH (2024) Mitochondrial dysfunction in diabetic nephropathy: insights and therapeutic avenues from traditional Chinese medicine. Front Endocrinol 15:1429420. https:\/\/doi.org\/10.3389\/fendo.2024.1429420","journal-title":"Front Endocrinol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05564-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:04:18Z","timestamp":1781773458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05564-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["5564"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05564-4","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments were reported according to the ARRIVE guidelines (\n                      \n                      ) and was approved by the Animal Ethics Committee of Heilongjiang University of Chinese Medicine (approval number: GENINK-20250068). All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}